Professor Chris Langmead a panelist at the PSYCH Symposium 2023
31 July 2023
Professor Chris Langmead joined a panel of experts at the PSYCH Symposium 2023, Access to Psychedelic Medicines session in London earlier this month.
PSYCH Symposium: London is Europe's leading psychedelic medicine conference, providing a stage for the industry’s most influential figures to connect, collaborate, and expedite the adoption of psychedelic healthcare.
Professor Langmead joined fellow panelists Dr Farrah Jarral, Dr Guy Goodwin (Chief Medical Officer, COMPASS Pathways) and Dr David Erritzoe (Clinical Director, Centre for Psychedelic Research, Imperial College London) to discuss the reality of the new psychedelic market and the complicated framework healthcare professionals and policymakers need to work within, and what can be learnt from recent developments in Australia.
Watch the session below.